Monaco Non-Alcoholic Steatohepatitis Treatment Market (2025-2031) | Analysis, Competitive Landscape, Growth, Industry, Size & Revenue, Segmentation, Share, Outlook, Companies, Trends, Forecast, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Monaco Country Macro Economic Indicators

3.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, 2021 & 2031F

3.3 Monaco Non-Alcoholic Steatohepatitis Treatment Market - Industry Life Cycle

3.4 Monaco Non-Alcoholic Steatohepatitis Treatment Market - Porter's Five Forces

3.5 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) globally

4.2.2 Growing awareness about the health risks associated with NASH

4.2.3 Advancements in medical research leading to the development of innovative non-alcoholic steatohepatitis treatments

4.3 Market Restraints

4.3.1 High costs associated with the treatment of non-alcoholic steatohepatitis

4.3.2 Lack of approved specific drugs for non-alcoholic steatohepatitis treatment

4.3.3 Regulatory challenges in the approval process of new treatments for NASH

6.1 Monaco Non-Alcoholic Steatohepatitis Treatment Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Obeticholic Acid (OCA), 2021- 2031F

6.1.5 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Lanifibranor, 2021- 2031F

6.1.6 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Semaglutide, 2021- 2031F

6.1.7 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Resmetirom, 2021- 2031F

6.1.8 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Aramchol, 2021- 2031F

6.1.9 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market, By End-use

6.2.1 Overview and Analysis

6.2.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.2.3 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Retail and Specialty Pharmacies, 2021- 2031F

6.2.4 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F

7.1 Monaco Non-Alcoholic Steatohepatitis Treatment Market Export to Major Countries

7.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Imports from Major Countries

8.1 Patient adherence rate to the prescribed treatment plan

8.2 Rate of adoption of new non-alcoholic steatohepatitis treatments by healthcare providers

8.3 Improvement in liver health biomarkers in patients undergoing treatment for NASH

9.1 Monaco Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Monaco Non-Alcoholic Steatohepatitis Treatment Market Revenue Share, By Companies, 2024

10.2 Monaco Non-Alcoholic Steatohepatitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters